AMEX · Healthcare · Medical Devices · USA
Electromed Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.
Electromed develops and sells the SmartVest System, a device providing high-frequency chest wall oscillation therapy for airway clearance in patients with compromised lung function, including those with bronchiectasis, cystic fibrosis, and neuromuscular conditions. The company operates through a direct-to-patient model, managing insurance and delivering systems to homes, while also serving acute care hospitals.
From its FY2026 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Electromed Inc stock.
Undervalued: intrinsic value $30.06 per share, market price $23.13, margin of safety 23.1% (as of 2026-11-17).
Discounting its cash flows at 8.2% (average of 3 methods) values the shares at $30.06; the price of $23.13 is 23% below that value, and 80% of that value comes from beyond year five.
17 more funds hold it; the full list is part of the paid plan.
All 140 Medical Devices stocks
6 more in this industry show a wider margin of safety.
ELMD is undervalued (as of the 2026-11-17 close). Discounting its cash flows at 8.2% (average of 3 methods) values the shares at $30.06; the price of $23.13 is 23% below that value, and 80% of that value comes from beyond year five.
$30.06 per share (as of the 2026-11-17 close), against a market price of $23.13. That is a margin of safety of 23.1%. The value is the average of the 3 valuation methods that apply to this company, recomputed every night after the US close.